I'll research this company before drafting.
ClearCorrect Pakistan (Private), Ltd. is a Pakistani entity based in Lahore that performed digital orthodontic treatment planning for ClearCorrect, the clear-aligner brand founded in 2006 and headquartered in Round Rock, Texas (originally Houston). ClearCorrect was privately held until October 2017, when Straumann Group (SIX: STMN, Basel, Switzerland) acquired ClearCorrect Holdings, Inc. and its subsidiaries for approximately USD 150 million. Straumann reported ClearCorrect at roughly USD 32 million in 2016 sales and about 200 employees at the time of the deal; headcount, revenue, and registration data specific to the Pakistan entity are not publicly disclosed.
Operations. ClearCorrect Pakistan processed scans of patients' teeth into treatment plans and digital data sets, which were transmitted electronically to the U.S. operations, where models were 3D printed and thermoplastic aligners manufactured and shipped to dentists. It was the group's offshore treatment-planning arm, not a customer-facing company, and is not a patent-asserting or licensing entity.
Litigation posture: pure defendant. It appears in all six tracked matters as a defendant and zero as a plaintiff, entirely as a target of Align Technology's patent campaign against ClearCorrect. The tracked venues are the U.S. International Trade Commission — the Section 337 investigation plus two enforcement proceedings concerning a 2006 OrthoClear consent order — and the Federal Circuit.
Notable context. The core matter was ITC Inv. No. 337-TA-833. On appeal, the Federal Circuit's 2015 decision in ClearCorrect Operating, LLC v. ITC, 810 F.3d 1283, held that electronically transmitted digital data are not "articles" under Section 337, limiting ITC jurisdiction over digital imports; rehearing en banc was denied in March 2016. In March 2019 Align and ClearCorrect settled all outstanding disputes, with a USD 35 million payment to Align, a contingent additional USD 16 million, and a five-year scanner-integration agreement with Straumann.